EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective efficacy of mutant strains of Borrelia burgdorferi as potential reservoir host-targeted biologics against Lyme disease

Venkatesh Kumaresan iD, Trever C Smith, Miranda Lumbreras, Taylor MacMackin Ingle, Nathan Kilgore, Jolie F Starling-Lin iD, Elizabeth J Horn iD, J Seshu iD

Infection and Immunity · 14.07.2026 · 94 (7)

DOI: 10.1128/iai.00210-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Immunity, erschienen am 14.07.2026. Verfasst von Venkatesh Kumaresan und 7 weiteren Autor:innen. Beteiligte Einrichtung: South Texas Center for Emerging Infectious Diseases, Department of Molecular Microbiology and Immunology, The University of Texas at San Antonio, San…. Hauptthemen laut MEDLINE: Lyme Disease, Borrelia burgdorferi, Bacterial Vaccines, Lyme Disease Vaccines. Die Arbeit nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lyme disease (LD), caused by Borrelia burgdorferi ( Bb ), is the most common vector-borne disease in the United States. Novel strategies to control transmission of Bb to humans via ticks are critical for the prevention of LD. One such strategy is to leverage non-infectious mutant strains of Bb for pathogen-derived biologics to block Bb transmission during the natural infectious cycle. Deletion of B orrelia host- ad aptation R egulator ( ΔbadR ) and replacement of eight conserved residues with alanines in Carbon Storage Regulator A of Bb (8S) resulted in mutants with upregulation of RpoS and several immunogenic lipoproteins, that were incapable of colonization in C3H/HeN mice. Intradermal vaccination of mice with the live mutant strains resulted in significant anti-borrelial antibody responses and a reduction in Bb acquisition by naïve Ixodes scapularis larvae following needle challenge with Bb B31-A3. While vaccination with the ΔbadR mutant conferred a significant reduction in the percentage of infected mice, ML23 and 8S mutants conferred variable levels of protection. Comparative proteomic analysis of purified borrelial lipoproteins (PBLs) from parental and mutant strains revealed similar and unique antigenic components. Infection-derived mouse serum and serum from Lyme disease patients exhibited reactivity to lysates and PBLs from these mutants. Immunization with PBLs from B31-A3 and 8S strains conferred significant protection against challenge with Bb -infected nymphs, underscoring the utility of PBLs as protective formulations. Overall, non-infectious mutant strains, or their lipoproteins, can be exploited as biologics to block the acquisition of Bb by naïve larvae from reservoir hosts, thereby disrupting the enzootic transmission cycle of the agent of Lyme disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lyme DiseaseBorrelia burgdorferiBacterial VaccinesLyme Disease VaccinesAnimalsMice, Inbred C3HMiceLipoproteinsFemaleAntibodies, BacterialIxodesBacterial ProteinsMutationHumansAntigens, BacterialDisease Models, AnimalDisease Reservoirs

Stichwörter der Autor:innen

Borrelia burgdorferiLyme diseaselipoproteinsmouse models of infectionprotective immunity

Substanzen

LipoproteinsAntibodies, BacterialBacterial ProteinsBacterial VaccinesAntigens, BacterialLyme Disease Vaccines

Autor:innen und Institutionen

  • South Texas Center for Emerging Infectious Diseases, Department of Molecular Microbiology and Immunology, The University of Texas at San Antonio, San Antonio, Texas, USA.
  • Bay Area Lyme Foundation, Portola Valley, California, USA.

ORCID-Profile: Venkatesh Kumaresan, Jolie F Starling-Lin, Elizabeth J Horn, J Seshu

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Kumaresan, V., Smith, T. C., Lumbreras, M., MacMackin Ingle, T., Kilgore, N., Starling-Lin, J. F., Horn, E. J., & Seshu, J. (2026). Protective efficacy of mutant strains of Borrelia burgdorferi as potential reservoir host-targeted biologics against Lyme disease. Infection and Immunity, 94(7). https://doi.org/10.1128/iai.00210-26

Vancouver

Kumaresan V, Smith TC, Lumbreras M, MacMackin Ingle T, Kilgore N, Starling-Lin JF, et al. Protective efficacy of mutant strains of Borrelia burgdorferi as potential reservoir host-targeted biologics against Lyme disease. Infection and Immunity. 2026;94(7). doi:10.1128/iai.00210-26

BibTeX
@article{Kumaresan2026,
  author = {Kumaresan, Venkatesh and Smith, Trever C and Lumbreras, Miranda and MacMackin Ingle, Taylor and Kilgore, Nathan and Starling-Lin, Jolie F and Horn, Elizabeth J and Seshu, J},
  title = {Protective efficacy of mutant strains of Borrelia burgdorferi as potential reservoir host-targeted biologics against Lyme disease},
  journal = {Infection and Immunity},
  year = {2026},
  volume = {94},
  number = {7},
  doi = {10.1128/iai.00210-26}
}
Kostenlos starten →